risk of pulmonary fibrosis with nitrofurantoin
Published 11 months ago • 1.1K plays • Length 0:38Download video MP4
Download video MP3
Similar videos
-
1:29
using chip to encourage early intervention in disease
-
5:50
dominic kwiatkowski: genomics and global health
-
49:38
clinical research
-
39:52
'computer analysis of fibrosing lung diseases' by dr joseph jacob
-
1:07
checkpoint inhibitors for lung cancer: combating resistance
-
2:46
dr. matthew pamenter - researching hypoxia and related adaptations
-
4:46
gfpd | the mission of the gfpd | full length
-
4:51
genetic profiling for blood brain barrier diseases – life in real-time with dr. joel pachter
-
0:46
oncotarget: smurf2 regulation of hif-1α in cancer cells
-
2:20
inr deviations
-
1:33
improving inr deviations
-
3:29
cardiac toxicity of immune-checkpoint inhibitors – id 185202
-
3:36
outcomes of patients with newly diagnosed crlf2-rearranged b-all
-
1:25
dr. halmos on immune checkpoint inhibitors in nsclc
-
1:11
hypoxia in the tumor microenvironment drives radiation resistance
-
15:26
clinical case: focus on drug resistance | miłosz parczewski, md, phd
-
3:16
using droplet digital™ pcr to diagnose leukemia
-
6:08
2023 virtual symposium: risk of cancer from medical imaging